Sarah Cannon Research Institute
Jordan Harbison has a strong background in biomolecular science and biology, holding a Master's degree from Lipscomb University and a Bachelor of Science from Kentucky Wesleyan College. Currently serving as a Phase II/III Data Coordinator and Tissue Coordinator at Sarah Cannon Research Institute since February 2016, Jordan has developed expertise in data coordination within clinical research. Prior to this role, Jordan gained experience as a Surgery Attendant at UT Medical Center from November 2014 to December 2015 and worked as a Sales Consultant at KNOX Rail Salvage Inc from May 2007 to August 2014.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.